吗替麦考酚酯治疗与系统性硬化症甲襞血管改善相关
前瞻性队列纳入80例新诊断系统性硬化症患者,回顾性筛选出随访48个月内至少完成两次甲襞毛细血管显微镜检查者。中位随访27个月,28例患者按指分析毛细血管密度改善;吗替麦考酚酯(MMF)与毛细血管密度恶化指数量减少相关,抗拓扑异构酶抗体与低平均毛细血管密度相关。
要点
- MMF治疗与较少的毛细血管密度恶化指数量相关。
- 抗拓扑异构酶抗体与低平均毛细血管密度相关。
- 抗RNA聚合酶III抗体与按指分析毛细血管密度改善相关。
核心结论
- 相当比例系统性硬化症患者甲襞毛细血管密度随时间改善。
- MMF治疗对这些患者毛细血管密度的演变有正面影响。
- 系统性硬化症自身抗体表型可能影响毛细血管密度发展。
- 数据支持既往假说:早期免疫抑制可能有利影响系统性硬化症血管再生。
研究设计与样本
- 前瞻性研究队列,连续纳入新诊断系统性硬化症患者,回顾性筛选随访48个月内至少完成两次甲襞毛细血管显微镜检查者。
- 共80例患者(68例女性,12例男性)符合纳入标准,中位随访时间27个月。
- 采用宽视野甲襞毛细血管显微镜测量每3 mm毛细血管密度,分析每指毛细血管密度改善及平均毛细血管密度。
- 纵向平均毛细血管密度测量采用广义估计方程分析。
主要发现
- 28例患者按指分析毛细血管密度改善。
- MMF与较少的毛细血管密度恶化指数量相关。
- 抗拓扑异构酶抗体与低平均毛细血管密度相关。
- 按指分析中,抗RNA聚合酶III抗体与毛细血管密度改善相关,抗着丝点抗体与毛细血管密度恶化相关。
- 在包含抗拓扑异构酶抗体存在及MMF与随访时间交互项的调节广义估计方程模型中,MMF治疗与较平缓的毛细血管密度下降相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the evolution of nailfold capillary density in patients with SSc in relation to immunosuppressive treatment and autoantibodies. METHODS: This was a prospective study cohort. Consecutive newly diagnosed SSc patients were included into this study who, in a retrospective review, had at least two nailfold capillary microscopy measurements performed during the first 48 months of follow-up. Capillary density per 3 mm was measured with widefield nailfold capillary microscopy. Improvement of capillary density per finger and mean capillary density were analysed. Longitudinal measurements of mean capillary density were analysed by generalized estimating equation. RESULTS: Eighty patients (68 women, 12 men) met the inclusion criteria. The median follow-up time was 27 months. Twenty-eight patients had an improved capillary density in per-finger analysis. MMF was associated with fewer numbers of fingers that had worsened in capillary density. Anti-topoisomerase antibodies were associated with low mean capillary density. Anti-RNA polymerase III antibodies were associated with improvement and anti-centromere antibodies with worsening of capillary density in per-finger analysis. MMF treatment was associated with less steep capillary density decline in a moderated generalized estimating equation model including presence of anti-topoisomerase antibodies and the interaction of MMF with follow-up time. CONCLUSION: Nailfold capillary density improved over time in a substantial proportion of SSc patients. MMF treatment had a positive impact on the evolution of capillary density in these patients. SSc autoantibody phenotype may affect the capillary density development. The data support previous hypotheses that early immunosuppression may favourably affect vascular regeneration in SSc.
引用
- Wildt M, Andréasson K, Hamberg V, et al. Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis. Rheumatology (Oxford). 2024. PMID: 37158586. doi:10.1093/rheumatology/kead207
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。